(1)
van de Kerkhof, P.; Reich, K.; Leonardi, C.; Blauvelt, A.; Mehta, N.; Tsai, T.; You, R.; Papanastasiou, P.; Milutinovic, M.; Griffiths, C. Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment. J of Skin 2018, 2, S18.